EAGLE PHARMACEUTICALS, INC. 3 SEC Filings

Filed On	Filing
19 Nov 2024	Form 3: Krawtschuk Christopher, Chief Financial Officer No securities owned
07 Oct 2021	Form 3: Moran Michael Shawn, EVP, Chief Commercial Officer Holds 24,268 shares of Common Stock
30 Apr 2021	Form 3: Borio Luciana, Director No securities owned
09 Nov 2020	Form 3: Cahill Brian Joseph, Chief Financial Officer Holds 15,286 shares of Common Stock
02 Nov 2020	Form 3: Ng-Cashin Judith, Chief Medical Officer No securities owned
05 Sep 2019	Form 3: Simpson Jennifer K., Director No securities owned
15 May 2017	Form 3: Meyers Pete A., Chief Financial Officer No securities owned
21 Mar 2017	Form 3: Edlin Richard A., Director Holds 23,400 shares of Common Stock
06 Jul 2016	Form 3: Braunstein Douglas L, Director Holds 950,600 shares of Common Stock
06 Jul 2016	Form 3: Glenning Robert, Director Holds 0 shares of No Securities are beneficially owned.
24 May 2016	Form 3: ProQuest Financial Llc, 10% owner Holds 4,770,828 shares of Common Stock, $0.001 par value
10 Apr 2015	Form 3: Pernock David, Director Holds 0 shares of No securities are currently owned by the Reporting Person
23 Mar 2015	Form 3: Hepner Adrian, Executive VP
11 Feb 2014	Form 3: ProQuest Associates Iv Llc, 10% owner and 2 others Holds 39,001 shares of Common stock, $0.001 par value
11 Feb 2014	Form 3: Schreiber Alain, Director Holds 39,001 shares of Common stock, $0.001 par value
11 Feb 2014	Form 3: Riggs David E, Chief Financial Officer
11 Feb 2014	Form 3: Tarriff Scott, Director Holds 1,472,374 shares of Common Stock
11 Feb 2014	Form 3: Ratoff Steven B, Director Holds 9,360 shares of Common Stock
11 Feb 2014	Form 3: Moorin Jay, Director Holds 39,001 shares of Common stock, $0.001 par value
11 Feb 2014	Form 3: Krill Steven L., Chief Scientific Officer

Comments